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Background. Proximal patellar tendinopathy is relatively common among sportsmen. 
However, the strength profile of subjects with proximal patellar tendinopathies is poorly 
described. Purpose. We aimed to determine the isokinetic strength profile in order to 
estimate the difference of muscular performance between the healthy and pathological 
limbs of subjects suffering of this chronic pathology. Study design. cohort study. Meth-
ods. 43 subjects with chronic proximal patellar tendinopathy were involved. It has been 
based on the evaluation of the quadriceps and the hamstrings muscular performance of 
the healthy and pathological member on isokinetic dynamometer at the speed of 60°/s 
(C60) and of 240°/s (C240) in concentric mode and at the speed of 30°/s (E30) in eccen-
tric mode. A visual analogic scale of pain (VAS) has been also realized after each isokinet-
ic test. Results. The results of the isokinetic tests comparing the healthy to the patholog-
ical limb are meaningful for the different conditions of contraction and test speeds, just 
like the results of the VAS associated to those tests (p<0,01). Indeed, pathological knees 
had a maximum peak torque for the quadriceps in C60 lower than healthy. Conclusion. 
In our study, the isokinetic results show a significant difference in performance isokinetic 
between the healthy and the pathological limb as well as VAS associated with these tests. 
However, the diversity of outcomes recorded in the patients suggests us that an individ-
ualized treatment is the case of patellar tendon pathology. Finally, it would seem that an 
isokinetic test in eccentric in some patients is, in addition to a test of provocation of the 
tendon, a pain assessment tool. 
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INTRODUCTION
Patellar tendinopathy (PT) is relatively common among 
sportsmen (3,7,9). Its incidence is reported to be in the 
range of 7 – 40% (14). Proximal patellar tendinopathies, 
also called jumper’s knee (JK) represent two thirds of all 
overuse pathologies of the knee induced by volleyball or 
basketball practice (14). Nearly one volleyball player out 
of 2 will suffer from this tendon condition during his sport 
career. Even if there exist lots of study to understand its 
physiopathology, to evaluated its mechanical repercussions 
and to propose treatments (1,4,10-11,17,19-23), howev-
er, the quadriceps strength profile of subjects with prox-
imal patellar tendinopathies remains poorly described. 
Indeed, due to the knee pain among subjects with PT, the 
quadriceps could be deconditioned and its strength could 
decrease. Moreover, this decrease of strength could persist 
after the decrease or disappearance of patellar tendon pain. 
So, a specific strengthening of the quadriceps could be 
useful before return to play for some patients who have to 
be identified.
Thus we aimed to determine the strength profile (difference 
of muscular performance between the healthy and patholog-
ical limb measure by an isokinetic dynamometer) of subjects 
suffering of this chronic pathology. This could perhaps 
provide the therapist with rationale information contribut-
ing to adapt their treatment for patient in such condition.
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MATERIALS AND METHODS
This protocol of our cohort study was reviewed and accept-
ed by the Ethic Committee of the University of Liège.
Patients
43 patients (42 males, age = 29.1 y.o. +/- 9.9 y.o., weight = 
78.6 kg +/- 11.8 kg, height = 1.79 m +/- 0.07 m), all leisure 
sportsmen and suffering from chronic (more than 3 months) 
proximal PT were recruited in the Physical and Rehabilita-
tion Department of the University Hospital of Liège. To be 
eligible, the patients must not have suffered from any other 
traumatic or micro-traumatic injury than the proximal PT 
on the pathologic limb, including 
• muscular lesions (quadriceps, hamstrings, sural triceps),
ligamentar lesions ( ACL, ILL and ELL), meniscal and 
tendineous.
• chondropathy and pattelar instability
• knee surgery
• any other tendinopathy of the knee extensor.
An informed consent form explaining the different modali-
ties of the study was read and approved by the patients.
The PT was confirmed by a clinical examination (and VISA-P 
[12]) and a Doppler ultrasonography. The patients were then 
evaluated with isokinetic protocols and a pain assessment was 
performed by mean of a visual analog scale (VAS).
Physical examination and ultrasonography
After a thorough anamnesis, the clinician performed a phys-
ical examination. The tendon’s damage was assessed by 
ultrasound (US) examination with a 8-15 MHz probe (Logiq 
S7, GE, Connecticut, USA) performed by the same investi-
gator. The following pieces of information were recorded: 
echo-texture, tendon maximal thickness, ratio between the 
thickness of the pathological and the healthy parts of the 
tendon, axial and sagittal hypo-echoic length and amount of 
neovascularization using colour Doppler.
Isokinetic testing
Isokinetic measurements of the quadriceps and hamstrings 
were conducted using the Cybex Norm dynamometer 
(Lumex, NY, USA). Before the tests, the patients warmed 
up by pedaling on a stationary bike during 10 minutes at a 
light intensity (50 – 100 Watts). 
The subject was asked to sit on the dynamometer seat with 
his back reclined at 85°. The subject was stabilized using 
thigh, pelvic and shoulder straps. In particular, the thigh 
strap prevented simultaneous hip and knee flexion during 
testing of the hamstring. The resistance pad was adjusted to 
face a point 3 cm above the malleoli. Before the actual test 
begun, the subject performed three series of 5 progressively 
intensified submaximal contractions. Both the pathological 
and the control legs were tested according to the following 
modalities:
• Quadriceps – 3 concentric repetitions at 60°/s (QC60)
• Quadriceps – 5 concentric repetitions at 240°/s (QC240)
• Quadriceps – 3 eccentric repetitions at 30°/s (QE30)
• Hamstring – 3 concentric repetitions at 60°/s (HC60)
• Hamstring – 5 concentric repetitions at 240°/s (HC240)
For all tests, the angular amplitude was fixed to 100°. Before 
each of these series, the subject was asked to perform 3 
sub-maximal repetitions at the prescribed speed. The peak 
torque (PT) and the bodyweight normalized PT (PT/kg) 
were recorded and a VAS test was performed after each 
modalities for the quadriceps. The quadriceps was also 
tested in eccentric at 30°/s. This mode of contraction and 
angular velocity were selected for the following reasons: 
1) because eccentric allows to develop a higher strength
in comparison with concentric mode, testing in eccentric 
should induce an increased mechanical stress in the tendon; 
this could be of interest in order to assess the patient’s pain 
2) in eccentric, it is easier to familiarize with a low velocity in
comparison with high velocities. For this reason, low veloci-
ty warrants more accurate and safe measurements.
Statistical analysis
For each test, we ensured the data followed a normal distri-
bution through a Shapiro-Wilk test. We then performed 
paired t-tests to determine if a significant difference exist-
ed between the PT (resp. PT/kg) values of the healthy and 
pathological limb. We also checked for correlation between 
the difference in PT (resp. PT/kg) values between the 
healthy and pathological limb and the demographic vari-
ables, the US variables and the inter-limb pain difference as 
expressed by the VAS.
RESULTS
A. In this section are presented the synthetic results for each 
of the afore mentioned analyses for all the 43 patients with 
chronic patellar tendinopathy.
Ultrasonography
The mean anteroposterior thickness of the pathological 
tendon is 8.1 mm (+/- 2.1 mm) and the associated patho-
logical thickness to healthy thickness ratio is 1.76 (+/- 0.24 
212 Muscles, Ligaments and Tendons Journal 2019;9 (2)
Isokinetic strength profile of subjects with proximal patellar tendinopathy
mm). The axial and sagittal hypo-echoic length are 6.8 mm 
+/- 6.1 mm and 19.0 mm +/- 7.4 mm respectively.
Isokinetic protocol
Table 1 shows the mean and standard deviation MT values 
obtained for each protocol. The MTm results are presented 
as whisker plots in Figure 1 and Figure 2. Looking at the 
values in Table 1, one can see that albeit the values for the 
E30 tests are fairly similar those for the C60, the difference 
between the healthy and the pathologic limb is not signifi-
cant. This observation is to be attributed to the inter-indi-
vidual variability (Figure 3).
Visual analog scale
We report in Table 2 the mean values and standard devia-
tion for the difference in VAS value between the two legs. 
The difference between the results at E30 are significant-
ly higher than for the other two protocols. The eccentric 
loading induces a higher mechanical stress on the tendons, 
hence resulting in a stronger pain in the pathologic limb.
B. From this section to the end of the report, we adopt 
the convention that « ∆variable » stands for the arithmetic 
difference between the value of « variable » for the patho-
logic limb and the healthy limb.
Table I. Maximum torque mean values and standard deviations for each isokinetic protocol. (*) indicates a significant 
difference between the healthy and the pathologic limb.
E30 C60 C240
Quadriceps Healthy (N.m) 199.6 ± 72.0 193.4 ± 35.6 123.2 ± 27.4 
Pathologic (N.m) 174.8 ± 67.3 170.5 ± 44.6 (*) 114.3 ± 30.0 
Hamstrings Healthy (N.m) 103.6 ± 22.8 66.0 ± 15.0 
Pathologic (N.m) 97.2 ± 21.9 (*) 63.1 ± 13.5 
Figure 1: Bodyweight normalized peak torque whisker plot for the quadriceps. P=Pathologic, H=Healthy, 
E=Eccentric, C=Concentric
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Table II: Pain difference between the pathologic and the contralateral limb assessed by a visual analog scale
∆ VAS QE30 ∆ VAS QC60 ∆ VAS QC240
5.08 +/- 3.02 3.43 ± 2.80 2.84 ± 2.35
Figure 3: Bodyweight normalized peak torque difference scatter plot for the quadriceps
Figure 2: Bodyweight normalized peak torque whisker plot for the hamstrings. P=Pathologic, 
H=Healthy, E=Eccentric, C=Concentric
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Demographic variables 
Statistically significant correlation was found between the 
patients’ height and the hamstrings ∆PT/kg at both C60 (r 
= 0.38, p = 0.014) and C240 (r = 0.3, p = 0.05). No other 
correlation was found involving demographic variables.
US variables
Although it is generally admitted that there seems to be 
no correlation between muscle strength pain, and imagery, 
we found that the ∆ PT/kg for the QE30 was negatively 
correlated with the patellar tendon axial hypo-echoic zone 
length (r = -0.4, p = 0.009) and with the anteroposterior 
dimension (r = -0.36, p = 0.02). We also found a positive 
correlation between the pathologic to healthy tendon thick-
ness ratio and ∆VAS for the quadriceps in E30 (r = 0.32, p = 
0.05) and in C60 (r= 0.32, p = 0.04).
Peak torque and bodyweight normalized  
peak torque
Only the PT/kg for the quadriceps (p=0.03) and the 
hamstrings (p=0.04) in C60 were significantly different 
between the two legs, and this despite the relatively import-
ant inter-individual variability. Indeed, there were as many 
(12) patients with a 25% and more relative difference in 
peak torque per mass unit as there were with a 10% and less 
for the C60 test.
Visual analog scale
The ∆VAS were all significantly different from 0, with p 
values inferior to 5e-9. A correlation was found between 
∆PT/kg QC60 and the corresponding VAS (r = -0.36, p = 
0.026).
DISCUSSION
The physiopathology and the tretaments of tendinopathies, 
and especially of the patellar tendinopathy, are more and 
more studied but remain not clearly understood (1,4,13,16-
17,19-23). Moreover, the repercussion of this condition on 
strength of the thigh is poorly described. Thus in our original 
series, we aimed to objective the precise isokinetic concen-
tric and eccentric strength profile of subjects with JK. These 
observations could help physicians to take care and improve 
the treatment of these patients. Indeed, the latter generally 
aims to clearing the symptoms and restoring the tendon’s 
structure and ability to bear loads. However, few to no study 
has been devoted to the investigation of the loss of muscular 
strength in the pathological limb (1,4,17,19-23). Thus, the 
main objective of this report was to quantify this parameter 
and look for a trend in the muscle weakness and muscular 
unbalance between the two legs after recovery. 
The important scatter in the isokinetic protocol (Table 1, 
Figure 1 and Figure 2) results clearly demonstrate the non 
existence of a consistent muscle strength PT(/kg)-based 
profile at different loading velocities, and underlines the 
importance for the clinicians to apply a personalized treat-
ment to each patient in order to recover his maximum force.
It is therefore relevant, in the case of a patellar tendinop-
athy, to assess the quadriceps strength (with an isokinetic 
dynamometer) at the end of the prescribed treatment to 
evaluate the recovery (15).
The relationship between the ∆PT/kg for the quadriceps 
tested in eccentric mode and the measurements made on the 
ultrasound images is of greater interested as it relates togeth-
er an objective, functional measurement of the patient’s 
force deficit with an objective, anatomical measurement of 
the amount of damage to the tendon. 
It is generally admitted that the pain felt by the patient 
caused by its tendinopathy is not necessarily reflective of 
the tendon’s damage (2,4,5,18). However, in our study, the 
pain assessment was realized after an isokinetic protocol 
that caused mechanical stress on the tendon in a repeat-
able manner. Therefore, the fact that we found a correlation 
between the ∆VAS for E30 and the pathologic to healthy 
tendon thickness ratio does not seem contradictory to the 
accepted observation that the tendon’s appearance on ultra-
sound images is generally not a good indicator of the intrin-
sic pain felt by the patient.
Our results also suggest that the isokinetic test QC60 is the 
one that can emphasize the force deficit caused by the tendi-
nopathy on the pathologic limb and could be an indicator of 
good evolution after treatement (10), while the E30 caused 
the most intense pain. A force deficit is an indicator that the 
treatment must be continued to achieve a full recovery. 
Finally, according to the VAS results, the isokinetic eccentric 
testing of the quadriceps induces a significantly more intense 
pain than the concentric protocols (6). Its physiopatholog-
ic mechanism is also the same than the one that caused the 
injury (1,22). Therefore, it can be used to create a mechanical 
stress on the tendon for a reliable pain assessment. 
By comparing the pain before the first session of physical 
therapy and at the end of it in this repeatable manner, the 
effect of the treatment can be objectively quantified.
However, even though the inter-limb difference in PT 
in the E30 protocol does not possess a prognostic value, 
one can wonder about the tendon’s capacity to bear the 
sport-induced mechanical loads it is found to be not negli-
gible (1,22). On the other hand, this very test could cause a 
secondary injury as it is likely to be more demanding on the 
musculotendinous system than the sport activity. Clinicians 
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should therefore balance the pros and cons of this particu-
lar protocol.
In our study, it was not possible to obtain the PT values on 
both legs since the patients were tested with an existing inju-
ry. It would be interesting to design a new study for which 
the participants would be followed regularly until full recov-
ery is assessed.
CONCLUSION
In this study, we investigated a muscle strength loss profile 
in patients suffering from proximal pattelar tendinopa-
thy. Amongst the five isokinetic protocols used, we found 
out that the quadriceps concentric contraction at 60 deg/s 
was the only one that consistently displayed a significant 
strength difference between the pathologic and the contra-
lateral limb. 
Our observations suggest that the treatment of subjects 
with JK should be individualized and that an isokinetic test 
should be carried out at the end of rehabilitation program. 
This way, the therapist will evaluate the individual strength 
profile of his patient and adapt his treatment in consequenc-
es, possibly decreasing the risk of other injury or re-injury.
Sub-maximal eccentric programs are frequently used for 
treating tendinopathies. Yet, according to our best knowl-
edge, the use of maximal eccentric contractions in jumper’s 
knee testing is poorly described. Its antagonistic function 
might induce the pain felt in the tendons. Furthermore, it is 
well established that the force developed in eccentric load-
ing is higher than its concentric counterpart and implicit-
ly creates more mechanical stress on the musculotendinous 
structures. It should therefore be a good indicator of muscle 
strength deficit in the pathologic limb but also to induce 
a similar pain to that which can be felt under competitive 
conditions. This assessment could be included in the return 
to play tests after JK.
Finally, the QE30 protocol seems very indicated to induce 
repeatable mechanical stress on the tendon to consistently 
evalutate the pain experienced by the patients. 
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